Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Conformational Changes and Association of Membrane-Interacting Peptides in Myelin Membrane Models: A Case of the C-Terminal Peptide of Proteolipid Protein and the Antimicrobial Peptide Melittin.
Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Relationship Between Regional Atherosclerosis and Adjacent Spinal Cord Histology.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression.
Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment.
Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us).
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
[Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.
Autopsy-proven demyelination associated with infliximab treatment.
Unilateral internuclear ophthalmoplegia after minor head injury.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Short-Term Effect of BalanceWear Therapy on Mobility in Older Adults With Mobility Limitations.
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
Survey of Neurologist's Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure.
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Pages
« first
‹ previous
…
674
675
676
677
678
679
680
681
682
…
next ›
last »